Fluvoxamine maleate

• CAT Number: A000443
• CAS Number: 61718-82-9
• Molecular Formula: C15H21F3N2O2 • C4H4O4
• Molecular Weight: 434.40
• Purity: ≥95%
• Synonyms: MK-264
• Target: Serotonin Transporter
• Solubility: Soluble in DMSO > 10 mM
• Storage: 3 years -20C powder
• IUPAC Name: (Z)-but-2-enedioic acid;2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine
• InChI: InChI=1S/C15H21F3N2O2.C4H4O4/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18;5-3(6)1-2-4(7)8/h5-8H,2-4,9-11,19H2,1H3;1-2H,(H,5,6)(H,7,8)/b20-14+;2-1-
• InChIKey: LFMYNZPAVPMEGP-PIDGMYBPSA-N
• SMILES: COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F.C(=C\C(=O)O)\C(=O)O

Fluvoxamine maleate（Cat No.:A000443）is a selective serotonin reuptake inhibitor (SSRI) with the molecular formula C19H25F3N2O6, primarily used to treat obsessive-compulsive disorder (OCD) and depression. It works by inhibiting the reuptake of serotonin in the brain, enhancing serotonergic neurotransmission and improving mood and anxiety symptoms. Administered orally, it is available in tablet and extended-release forms. Fluvoxamine is also studied for its potential benefits in other psychiatric and neurological disorders. Common side effects include nausea, drowsiness, insomnia, and dry mouth. It may interact with other medications via cytochrome P450 inhibition, requiring careful monitoring.